Table 3. Univariable and adjusted linear regression predicting composite acceptability score in regional subsets of the primary study population.
Variable | Region III Adjusted Model | Region IV Adjusted Model | Region V Adjusted Model | Region X Adjusted Model | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Coeff. | (95% CI) | pvalue | Coeff. | (95% CI) | pvalue | Coeff. | (95% CI) | pvalue | Coeff. | (95% CI) | pvalue | |
Sex | ||||||||||||
Male | ─ | ─ | ─ | ─ | ─ | ─ | REF | ─ | ─ | ─ | ||
Female | 1.53 | (0.03 ─ 3.02) | 0.0452 | |||||||||
Age | ||||||||||||
18–25 | REF | REF | ||||||||||
26–35 | 1.49 | (-0.11 ─ 3.09) | 0.0681 | -3.12 | (-5.44 ─ -0.81) | 0.0082 | ||||||
36–45 | 1.45 | (0.01 ─ 2.89) | 0.0477 | ─ | ─ | ─ | ─ | ─ | ─ | -2.57 | (-4.63 ─ -0.52) | 0.0142 |
46–55 | 1.36 | (-0.14 ─ 2.85) | 0.0747 | -0.85 | (-2.95 ─ 1.24) | 0.4250 | ||||||
56 + | 2.23 | (0.67 ─ 3.78) | 0.0050 | -0.34 | (-2.45 ─ 1.77) | 0.7505 | ||||||
Self-rated understanding of LF | ||||||||||||
No knowledge | REF | REF | ||||||||||
Some knowledge | -0.96 | (-2.68 ─ 0.76) | 0.2729 | 4.76 | (0.97 ─ 8.55) | 0.0138 | ||||||
Average knowledge | ─ | ─ | ─ | -2.11 | (-3.67 ─ -0.54) | 0.0082 | ─ | ─ | ─ | 3.38 | (-0.52 ─ 7.28) | 0.0895 |
Good knowledge | -2.26 | (-4.13 ─ -0.40) | 0.0174 | 2.82 | (-1.01 ─ 6.66) | 0.1493 | ||||||
Very good knowledge | -0.64 | (-2.27 ─ 0.99) | 0.4405 | 5.96 | (1.81 ─ 10.11) | 0.0049 | ||||||
Mechanism of transmission ‡ | ||||||||||||
Worms | 2.50 | (0.92 ─ 4.08) | 0.0019 | |||||||||
Mosquitos | ─ | ─ | ─ | -1.99 | (-4.08 ─ 0.10) | 0.0614 | ─ | ─ | ─ | |||
Don’t know | -4.60 | (-7.81 ─ -1.39) | 0.0050 | |||||||||
Believes LF to be asymptomatic | ||||||||||||
Yes | 1.74 | (0.34 ─ 3.13) | 0.0146 | 2.34 | (0.87 ─ 3.81) | 0.0019 | ||||||
Maybe | 0.85 | (-0.68 ─ 2.39) | 0.2762 | 1.96 | (-0.48 ─ 4.41) | 0.1161 | ─ | ─ | ─ | ─ | ─ | ─ |
No | 1.11 | (-1.23 ─ 3.44) | 0.3536 | 3.33 | (1.56 ─ 5.09) | 0.0002 | ||||||
Unsure/Don’t know | REF | REF | ||||||||||
Number of times taken treatment | ||||||||||||
Never | REF | REF | REF | |||||||||
Once | 1.96 | (0.28 ─ 3.65) | 0.0219 | 3.43 | (2.00 ─ 4.86) | <0.0001 | 4.09 | (1.35 ─ 6.82) | 0.0034 | ─ | ─ | ─ |
Two or more times | 2.16 | (0.67 ─ 3.64) | 0.0045 | 1.45 | (0.24 ─ 2.67) | 0.0189 | 4.65 | (2.62 ─ 6.67) | <0.0001 | |||
Importance of MDA for community health | ||||||||||||
Not Important | * | REF | REF | |||||||||
Neutral | -1.24 | (-3.56 ─ 1.09) | 0.2965 | † | † | ─ | ─ | ─ | ||||
Important | 0.74 | (-1.63 ─ 3.11) | 0.5408 | 3.80 | (2.15 ─ 5.44) | <0.0001 | 2.42 | (1.04 ─ 3.80) | 0.0006 | |||
Don’t know | REF | * | † | |||||||||
Take LF pills even if not sick | ||||||||||||
Yes | 3.91 | (1.77 ─ 6.05) | 0.0003 | 1.83 | (0.13 ─ 3.52) | 0.0346 | ||||||
No | 2.79 | (0.11 ─ 5.47) | 0.0416 | REF | ─ | ─ | ─ | ─ | ─ | ─ | ||
Don’t know | REF | * |
* No data in this category.
† Collapsed into “Not important.”
‡ Mechanism of transmission was indicated through a multiple-response category. Regression estimates show indication vs no indication.
§ Education level attained, primary source of income, and perception of number of people in village with LF were included in the multivariable analyses but were not significant in any adjusted model.